Vaccination in the Time Of COVID-19: Survey Study at the University of Tlemcen in the Spring of 2022
DOI:
https://doi.org/10.26911/jepublichealth.2023.08.04.02Abstract
Background: The novel human coronavirus SARS-CoV-2 causing COVID-19 with symptoms ranging from the common cold to pneumonia, has been responsible for the current health crisis, it has spread rapidly at record speed leaving many deaths of different ages and different ethnicities, and in order to stop this propagation, scientists rushed to create several efficient vaccines against this virus, and despite being marketed in all countries of the world, opinions diverged between supporters and opponents. This prompted us to carry out this survey study on vaccination against COVID-19 at the University of Tlemcen, with the aim of exploring the perceptions and opinions of participants on vaccination and vaccines in general.
Subjects dan Method: A cross-sectional study was conducted over a two months period, using a questionnaire to collect data from Teachers and Students of the University of Tlemcen with a 382 calculated sample size, the survey was shared via email and social media networks. Variables of interest included exposure to the pathogen, the laboratory testing results, effectiveness and adherence to the preventive measures, while also monitoring the vaccine acceptance and hesitancy. Descriptive and statistical analysis were run on SPSS Statistics with a p-value <0.050.
Results: The majority of respondents for this study belonged to young people of the female gender (37.4%), despite the latter, men were the most vaccinated (53.4%), fortunately, most of them also acknowledge the association between prevention and vaccination (94.6%).
Conclusion: Vaccine reluctance is a huge problem in the face of a pandemic that is not yet over. Even with the availability of vaccines and vaccination campaigns, unexplained fear due to rumors and conspiracy theories on social media still wins over the public about the safety of these vaccines.
Keywords: COVID-19, SARS-CoV-2, investigation, vaccination, University of Tlemcen.
Correspondence:
Ilyes Zatla. Laboratory of Microbiology applied to the Food industry, Biomedical and the Environment, Faculty of Natural and Life Sciences, Earth and Universe Sciences. Department of Biology. University of Tlemcen, Algeria. E-mail: ilyes.zatla@univ-tlemcen.com. Mobile: +213540315422.
References
Forni G, Mantovani A (2021). COVID-19 vaccines: where we stand and challenges ahead. Cell death differ. 28: 626-639.
Global Health 50/50. (2022). The COVID-19 Sex–Disaggregated Dara Tracker. Available at: https://globalhealth5050.org/the-sexgender-and-covid-19-project/the-data-tracker/.
Kumar GR, Kumar PV. (2022). Spectrum of neurological complications following COVID-19 vaccination. Neurol Sci. 43(1): 3–40.
Laura R, Livio F, Buclin T. (2020). Treatments that aggravate a COVID-19 infection: really? Rev Med Suisse. 16: 852-4.
Ling R, Ramanathan K, Tan F, Tai B, Somani J, Fisher D, MacLaren G (2022). Myopericarditis following COVID-19 vaccination and non-COVID-19 vaccination: a systematic review and meta-analysis. Lancet Respir Med. 10(7): 679-688.
Mukherjee S, Pahan K (2022). Is COVID-19 Gender-sensitive?. J Neuroimmune Pharmacol. 16(1):38-47.
Pourani M, Shahidi Daras M, Salari M, Diab R, Abdollahmajd (2021). Cutaneous adverse events related to COVID-19 vaccines: Across-sectional questionnaire based study of 867 patients. Wiley Online Library. 35(2): e15223.
Samouh Y, Sefrioui M, Derfoufi S, Ben-moussa A (2021). COVID-19 Vaccine Acceptance Among Marrocan Students: A Cross-sectional Study. Pan Afr Med. 3: 381.
Wang J, Peng Y, Xu H, Cui Z, Wiiliams RO (2020). The COVID-19 vaccine race: challenges and opportunities in vaccine formulation. AAPS Pharm Sci Tech. 21(6): 225.
Weissleder R, Lee H, Ko J, Pittet M (2020). COVID-19 diagnostics in context. Sci Transl Med. 12:546.
Werf S, Peltekian C (2020). Emergence of the SARS-CoV-2 coronavirus: coping with the Covid-19 epidemic. Virologie.
WHO (2021). Potential efficacy, actual efficacy, and protection of vaccines. World Health Organization.
Zatla I, Boublenza L, Hassaine H (2021). Therapeutic and Preventive Approaches against COVID-19: a Review. RRJoMV. 11(3):26-33.
Zatla I, Boublenza L, Hassaine H (2022). Infection and Viral Pathogenesis of COVID-19: a Review. RRJoMV. 12(2).
Zeng N, Li Z, Ng S, Chen D, Zhou H (2020). Epidemiology reveals mask-wearing by the public is crucial for COVID-19 control. Med Microecol. 4: 100015.
